Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:VLNS

Valens (VLNS) Stock Price, News & Analysis

→ Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad)
Free VLNS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.76
▼
$0.76
50-Day Range
$0.64
▼
$0.81
52-Week Range
$0.58
▼
$3.00
Volume
N/A
Average Volume
221,089 shs
Market Capitalization
$61.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
VLNS stock logo

About Valens Stock (NASDAQ:VLNS)

The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands; and topical cannabis under the Nuance brand. It also offers analytical testing services to third party licensed producers in the cannabis space. The company is headquartered in Toronto, Canada.

VLNS Stock News Headlines

May 15, 2023 | proactiveinvestors.com
SNDL targets $30M in synergies from 1Q Valens acquisition by the end of 2024
April 2, 2023 | theglobeandmail.com
Closing Bell: The Valens Company Inc. down on Wednesday (VLNS)
March 4, 2023 | benzinga.com
Valens Semiconductor Stock (NYSE:VLN), Quotes and News Summary
January 17, 2023 | proactiveinvestors.com
The Valens Company acquisition wrapped up by Canada's largest private liquor and cannabis retailer SNDL
January 17, 2023 | msn.com
Cannabis Giant SNDL Grows Bigger: Finalizes Valens Acquisition Becoming 'A Leader And Trusted Partner' In Canadian Marijuana Space
January 4, 2023 | benzinga.com
Valens Obtains Final Court Order Approving Merger With SNDL
January 3, 2023 | msn.com
Why SNDL Stock Flew as High as 5% on Tuesday
December 14, 2022 | markets.businessinsider.com
Will Valens Remain On Nasdaq? It Has 180 Days to Regain Compliance With Minimum Bid Price Rule On This Stock Exchange
December 13, 2022 | finance.yahoo.com
The Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule
November 30, 2022 | proactiveinvestors.com
The Valens Company says shareholders overwhelmingly vote in favour of takeover by SNDL
November 30, 2022 | benzinga.com
Valens Shareholders Approve The Arrangement With SNDL
November 29, 2022 | prnewswire.com
Valens Shareholders Vote in Favour of the Arrangement with SNDL
November 22, 2022 | finance.yahoo.com
BOTH LEADING INDEPENDENT PROXY ADVISORS RECOMMEND SHAREHOLDERS OF THE VALENS COMPANY INC. VOTE FOR THE PROPOSED ARRANGEMENT WITH SNDL INC.
November 3, 2022 | msn.com
Valens Secures License To Sell Micro Processed Cannabis Products From Its Pommies Beverage Facility
November 3, 2022 | proactiveinvestors.com
The Valens Company receives sales licence amendment from Health Canada for its Pommies manufacturing facility
November 2, 2022 | finance.yahoo.com
Valens Secures Sales Licence for Greater Toronto Area Beverage Facility
October 28, 2022 | msn.com
The Valens Announces Mailing And Filing Of Circular For Special Meeting Of Shareholders To Approve Arrangement With SNDL
October 27, 2022 | finance.yahoo.com
THE VALENS COMPANY ANNOUNCES MAILING AND FILING OF CIRCULAR FOR SPECIAL MEETING OF SHAREHOLDERS TO APPROVE ARRANGEMENT WITH SNDL INC.
October 15, 2022 | proactiveinvestors.com
Stifel GMP analysts repeat ‘Buy’ rating and C$1.20 price target for The Valens Company on robust 3Q results
October 13, 2022 | proactiveinvestors.com
The Valens Company reports higher 3Q adjusted gross profit as integration initiatives kick in
October 13, 2022 | msn.com
Valens Shares Slightly Up On Declining Quarterly Revenue
October 13, 2022 | finance.yahoo.com
The Valens Company Reports Third Quarter Fiscal 2022 Financial Results
October 12, 2022 | seekingalpha.com
The Valens Q3 Earnings Preview
October 6, 2022 | finance.yahoo.com
The Valens Company to Release Financial Results for the Third Quarter of 2022
August 30, 2022 | apnews.com
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of The Valens Company Inc. (Nasdaq - VLNS)
See More Headlines

Company Calendar

Today
5/20/2024
Fiscal Year End
11/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:VLNS
CUSIP
N/A
CIK
1859902
Web
www.thevalenscompany.com
Phone
778-755-0052
Fax
N/A
Employees
445
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($2.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-39,110,000.00
Net Margins
-274.38%
Pretax Margin
N/A
Return on Equity
-48.02%
Return on Assets
-29.74%

Debt

Debt-to-Equity Ratio
0.80
Current Ratio
2.08
Quick Ratio
1.49

Sales & Book Value

Annual Sales
$62.37 million
Price / Sales
0.98
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.30 per share
Price / Book
0.58

Miscellaneous

Outstanding Shares
80,740,000
Free Float
77,696,000
Market Cap
$61.38 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Jeffrey Fallows C.F.A.
    L.L.B., M.B.A., CFA, Pres
  • Mr. Sunil Gandhi CPA
    Chief Financial Officer
  • Ms. Chantel Popoff
    Chief Operating Officer
  • Mr. Adam Shea
    Chief Commercial Officer
  • Mr. Scott Young
    Head of Investor Relations
  • Mr. Everett Knight C.F.A.
    Exec. VP of Corp. Devel. & Capital Markets
  • Mr. Anderson Smith
    Head of Regulatory Affairs
  • Mr. Daniel Howard
    VP, Bus. Devel.

Key Competitors

View All Competitors

This page (NASDAQ:VLNS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Elon to Transform U.S. Economy?
Porter & Company
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
"The Biggest Drug Ever" Is Coming
Behind the Markets
Most important medical advance in 100 years
The Oxford Club
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star